menu search

Deciphera raises $150m via equity offering

Deciphera pharmaceuticals Inc (NASDAQ: DCPH) has priced an underwritten public offering of 5.25 millio...

April 27, 2022, 7:55 am

Stevanato group to report first quarter 2022 financial results on may 10, 2022

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnost...

April 27, 2022, 7:50 am

Aptinyx to report first quarter 2022 financial results on thursday, may 12, 2022

EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical compan...

April 27, 2022, 7:47 am

Healthy dividends: organic growth points north for west pharmaceutical services

West pharmaceutical Services is becoming a vital component of the healthcare industry. West has provide...

April 26, 2022, 11:09 pm

Intelgenx to participate in the 2022 bloom burton & co. healthcare investor conference

SAINT LAURENT, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in ...

April 26, 2022, 4:45 pm

Why quoin pharmaceuticals stock is trading higher

Quoin pharmaceuticals (NASDAQ: QNRX) shares are trading higher Monday after the company announced it re...

April 25, 2022, 11:45 am

Nkarta stock skyrockets on heavy volume after upbeat results from cancer-treatment trial

Shares of Nkarta Inc. NKTX, +95.82% skyrocketed 92.8% in very active morning trading, enough to make the stock the biggest gainer and most active list...

April 25, 2022, 10:49 am

Catalyst pharmaceuticals to report first quarter 2022 financial results on may 10, 2022

The Company to Host a Conference Call and Webcast on May 11, 2022, at 8:30 AM ET The Company to Host a Conference Call and Webcast on May 11, 2022, at...

April 25, 2022, 8:03 am

Crinetics pharmaceuticals: endocrinology focus to pay off as multi-faceted pipeline makes progress

Shares have fallen by 15% since my 2019 recommendation. I provide a recap of the bullish thesis and recent events. Endocrinology is a unique field whe...

April 24, 2022, 10:39 am

Madrigal: clear path ahead

Among many non-alcoholic steatohepatitis (NASH) drug innovators, Madrigal pharmaceuticals is poised to ...

April 22, 2022, 2:09 pm

Is teva pharmaceuticals a brilliant contrarian pick?

Investing in this generic drugmaker would be a gamble, but there are reasons why it might be worth a look....

April 21, 2022, 9:05 am

Ampio pharma shares fall as fda rejects proposed change in knee osteoarthritis trial

Ampio pharmaceuticals Inc (NYSE: AMPE) received written responses from the FDA pursuant to a Type C me...

April 21, 2022, 6:29 am

Teva's (teva) schizophrenia drug gets crl from the fda

Teva pharmaceuticals (TEVA) and partner MedinCell's new drug application for risperidone to treat schiz...

April 20, 2022, 12:47 pm

Rockwell medical to present at noblecon18 investor conference

WIXOM, Mich. , April 20, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a bio...

April 20, 2022, 8:00 am

Fda rejects teva - medincell's schizophrenia candidate

Teva pharmaceutical Industries Ltd's (NYSE: TEVA) U.S. affiliate and MedinCell SA (OTC: MDCLF) have�...

April 20, 2022, 7:37 am

Atai life sciences to participate in upcoming april investor conference

NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage bio...

April 19, 2022, 12:26 pm

Earnings: johnson & johnson misses on revenue, suspends vaccine sales guidance

Yahoo Finance's Anjalee Khemlani joins the Live show to discuss earnings for Johnson & Johnson as well as the ...

April 19, 2022, 11:03 am

Ani pharmaceuticals to discuss first quarter 2022 financial results on may 10, 2022

BAUDETTE, Minn.--(BUSINESS WIRE)--ANI pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: A...

April 19, 2022, 6:50 am

Sage therapeutics to report first quarter 2022 financial results on tuesday, may 3, 2022

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company ...

April 19, 2022, 6:30 am

Verona pharma to report first quarter 2022 financial results and provide corporate update

LONDON and RALEIGH, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage bio...

April 19, 2022, 2:00 am


Search within

Pages Search Results: